Interferon beta-1a (Rentschler)

N/A

Report date: 2022/03/23 15:20:53

Base Information

Drug NameInterferon beta-1a (Rentschler)
Drug Alias NameHuman serum albumin-free interferon betaHSA-free IFN β-1aBiferonex
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon-alpha/beta receptor alpha chain antagonists
TargetsInterferon-alpha/beta receptor alpha chain
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRentschler
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRentschlerBiopartners Gmbh
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A